Updates

Previous updates to Tobacco in Australia: Facts & issues

  • Section 2.4 Expenditure on tobacco products, updated June 2021
  • Section 13.3 The price of tobacco products in Australia, updated June 2021
  • Section 3.23 Smoking, dementia and cognition, updated June 2021
  • Section 3.22 Poorer quality of life and loss of function, updated June 2021
  • Section 10.7 Market share and brand share in Australia, updated June 2021
  • Section 3.15 The impact of smoking on treatment of disease, updated June 2021
  • Section 3.14 Skin, updated June 2021
  • Section 3.4 Lung cancer, updated June 2021
  • Section 3.5 Other cancers, updated June 2021
  • Section 3.13 Musculoskeletal diseases, updated June 2021
  • Section 3.27 Health effects of smoking tobacco in other forms, updated May 2021
  • Section 3.8 Child health and maternal smoking before and after birth, updated May 2021
  • Section 3.9 Increased susceptibility to infection in smokers, updated May 2021
  • Section 3.7 Pregnancy and smoking, updated May 2021
  • Section 7.17 Contingency management/incentives, updated May 2021
  • Section 12.8 Menthol and confectionery/liqueur flavoured cigarettes, updated May 2021
  • Section 3.12 Gastro-intestinal diseases, updated May 2021
  • Section 14.3 Public education campaigns to discourage smoking: the Australian experience, updated May 2021
  • Section 13.6 Revenue from tobacco taxes in Australia, updated May 2021
  • Section 7.16 Pharmacotherapies, updated May 2021
  • Section 3.4 Lung cancer, updated May 2021
  • Section 3.5 Other cancers, updated May 2021
  • Section 3.18 Other conditions with possible links to smoking, updated May 2021
  • Section 2.3 Self-reported measures of tobacco consumption, updated May 2021
  • Section 6.8 Interactions between tobacco smoke and medications, updated May 2021
  • Section 11A.6 Packaging as promotion; International flow-on effects, updated April 2021
  • Section 18B.3 Electronic cigarettes; Extent of use, updated April 2021 
  • Section 2.0, Introduction: Trends in tobacco consumption in Tobacco, updated March 2021
  • Section 2.5, Industry sales figures as estimates for consumption, updated March 2021
  • Section 11A6, International flow-on effects, updated March 2021
  • Section 4.17, Health effects of secondhand smoke for infants and children, updated March 2021
  • Section 3.28 Health 'benefits' of smoking?, updated March 2021
  • Section 10.6 Retail value and volume of the Australian tobacco market, updated March 2021
  • Section 1.13 Smoking by Australian states and territories, updated March 2021
  • Section 1.10 Prevalence of smoking in other high-risk sub-groups of the population, updated March 2021
  • Section 1.12 Prevalence of use of different types of tobacco product, updated March 2021
  • Section 13.2 Tobacco taxes in Australia, updated March 2021
  • Section 13.10 Arguments against tax increases promoted by the tobacco industry, updated March 2021
  • Section 3.9.12 Coronaviruses and the COVID-19 pandemic, updated March 2021
  • Section 1.5 Prevalence of smoking—middle-aged and older adults, updated February 2021
  • Section 1.7 Trends in the prevalence of smoking by socio-economic status, updated February 2021
  • Section 1.8 Trends in prevalence of smoking by country of birth, updated February 2021
  • Section 3.25 Smoking compared with or in combination with other pollutants, updated February 2021
  • Section 4.5 Prevalence of exposure to secondhand smoke in the home, updated February 2021
  • Section 1.3 Prevalence of smoking—adults, updated February 2021
  • Section 1.4 Prevalence of smoking—young adults, updated February 2021
  • Section 18.3 Smoking reduction, updated February 2021
  • Section 4.5 Prevalence of exposure to secondhand smoke in the home, updated February 2021
  • Section 11.9 Retail promotion and access, updated February 2021
  • Section 3.24 Genetic influences on tobacco-caused disease, updated February 2021
  • Section 3.2 Respiratory diseases (excluding lung cancer), updated December 2020
  • Section 3.1 Smoking and cardiovascular disease, updated December 2020
  • Section 3.9 Increased susceptibility to infection in smokers, updated December 2020
  • Section 3.5 Other cancers, updated November 2020
  • Section 3.27 Health effects of smoking tobacco in other forms, updated November 2020
  • Section 5.10 Cultural background, updated November 2020
  • Section 5.8 The smoking behaviour of peers, and peer attitudes and norms, updated November 2020
  • Section 5.18 Uptake: a concluding note, updated November 2020
  • Chapter 19 FCTC, updated October 2020
  • Section 13.0 Introduction - The pricing and taxation of tobacco products in Australia, updated September 2020
  • Section 5.21 Reducing tobacco access and supply, updated September 2020
  • Section 5.17 Factors influencing uptake of smoking later in life, updated September 2020
  • Section 13.4 The affordability of tobacco products, updated August 2020
  • Section 18B.10 Key Australian and international position statements on e-cigarettes, health, and options for regulation, updated August 2020
  • Section 3.13 Musculoskeletal diseases, updated August 2020
  • Section 9.6 Smoking, ill health, financial stress and smoking-related poverty among highly disadvantaged groups, updated August 2020
  • Section 1.13 Smoking by Australian states and territories, updated August 2020
  • Section 13.2 Tobacco taxes in Australia, updated August 2020
  • Section 13.3 The price of tobacco products in Australia, updated August 2020
  • Section 3.32 Health effects of smoking other substances, updated August 2020
  • Section 10.5 Retailing of tobacco products in Australia, updated August 2020
  • Section 3.9 Increased susceptibility to infection in smokers, updated August 2020
  • Section 7.7 Factors that predict success or failure in quit attempts, updated August 2020
  • Section  7.12 Smoking and mental health, updated August 2020
  • Section 7.19 Interventions for particular groups, updated August 2020
  • Section 7.6 How smokers go about quitting, updated August 2020
  • Section 7.4 What finally prompts smokers to attempt to quit?, updated August 2020
  • Section 7.2 Quitting activity, updated August 2020
  • Section 1.2 Overview of major Australian data sets, updated August 2020
  • Section 1.13 Smoking by Australian states and territories, updated August 2020
  • Section 1.7 Trends in the prevalence of smoking by socio-economic status
  • Section 1.12 Prevalence of use of different types of tobacco product, updated August 2020
  • Section 18A.5 Regulating sale and promotion of smokeless tobacco, other jurisdictions, updated July 2020
  • Section 3.34 Public perceptions of tobacco as a drug, updated July 2020
  • Section 1.10 Prevalence of smoking in other high-risk sub-groups of the population, updated July 2020
  • Section 1.8 Trends in prevalence of smoking by country of birth, updated July 2020
  • Section 1.5 Prevalence of smoking - middle-aged and older adults, updated July 2020
  • Section 1.4 Prevalence of smoking - young adults, updated July 2020
  • Section 1.3 Prevalence of smoking - adults, updated July 2020
  • Section 18B.3 E-cigarettes; Extent of use, updated July 2020
  • Section 11.9.9 Public support for reducing retail promotion and access, updated July 2020
  • Section 10.17 Public attitudes to the tobacco industry, updated July 2020
  • Section 18A.2 Prevalence of use of smokeless tobacco in Australia, updated July 2020
  • Section 5.31 Uptake and Prevention: Other drug use, updated July 2020
  • Section 5.17 Factors influencing uptake of smoking later in life, updated July 2020
  • Section 3.31 Morbidity and mortality due to tobacco-caused disease and socio-economic disadvantage, updated July 2020
  • Section 2.4 Expenditure on tobacco products, updates July 2020
  • Section 3.9.11 Coronaviruses and the COVID-19 pandemic, updated July 2020
  • Section 13.3 The price of tobacco products in Australia, Figure 13.3.4, updated July 2020
  • Section 3.23 Smoking, dementia and cognition, updated July 2020
  • Section 3.17 Inflammatory conditions and autoimmune disease, updated June 2020
  • Section 3.5 Other cancers, updated June 2020
  • Section 3.22 Poorer quality of life and loss of function, updated June 2020
  • Section 3.16 Smoking and diabetes, updated June 2020
  • Section 3.9.11.2 COVID-19 pandemic, updated June 2020
  • Section 1.10, Fig1.10.1 Prevalence of smoking during any stage of pregnancy, updated June 2020
  • Section 3.14 Effects of smoking on the skin, updated June 2020
  • Section 3.10 Eye diseases, updated May 2020
  • Section 3.11 Dental diseases, updated May 2020
  • Section 3.19 Smoking and accidents, updated May 2020
  • Section 5.15 Tobacco advertising and promotion targeted at young people: updated May 2020
  • Section 18B.3 Extent of use: updated May 2020
  • Section 3.12 Gastro-intestinal diseases: updated May 2020
  • Section 3.3 Smoking and cancer: updated May 2020
  • Section 3.9 Increased susceptibility to infection in smokers: updated May 2020
  • Section 3.4 Lung cancer: updated May 2020
  • Section 3.20 Nicotine and carbon monoxide poisoning: updated May 2020
  • Section 18B.6 Potential negative impacts of e-cigarettes: updated May 2020
  • Section 18B.7 Potential positive impacts of e-cigarettes: updated April 2020
  • Chapter 19 The WHO Framework Convention on Tobacco Control: updated April 2020
  • Section 5.14 Opportunity to smoke: updated April 2020
  • Section 3.15 The impact of smoking on treatment of disease: updated April 2020
  • Section 18B.2 Advertising and promotion of e-cigarettes: updated April 2020
  • Section 18B.11 Public perceptions of e-cigarettes: updated April 2020
  • Section 5.13 Products and packaging created to appeal to new users: updated April 2020
  • Section 10.7 Market share and brand share in Australia: updated April 2020
  • Section 7.14 Cessation assistance: telephone- and internet-based interventions: updated March 2020
  • Section 7.15 Individual and group-based cessation assistance: updated April 2020
  • Section 7.1 Health and other benefits of quitting: updated March 2020
  • Section 7.16 Pharmacotherapies: updated March 2020
  • Section 9.3 Contribution of smoking to health inequality: updated March 2020
  • Section 3.26 Health effects of brands of tobacco which claim or imply delivery of lower levels of tar, nicotine and carbon monoxide: updated February 2020
  • Section 3.31 Morbidity and mortality due to tobacco-caused disease and socio-economic disadvantage: updated February 2020
  • Section 15.7.10 Summary of smokefree legislation across Australian states and territories: updated February 2020
  • Section 1.10.5 The prison population updated: February 2020
  • Section 9.6.6 Prison populations: updated February 2020
  • Section 7.19.10 Prisoners and others involved in the criminal justice system: updated February 2020
  • Section 5.12 Affordability of tobacco products: updated February 2020
  • Section 11.9.7.1 Types of licences: updated February 2020
  • Section 3.6 Reproductive health: updated February 2020
  • Section 3.7 Pregnancy and smoking: updated February 2020
  • Section 3.8 Child health and maternal smoking before and after birth: updated February 2020
  • Section 1.9 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders: updated February 2020
  • Section 16.4 Criminal cases against the tobacco industry: updated January 2020
  • Chapter 17 The economics of tobacco control: updated January 2020
  • Chapter 19 The WHO Framework Convention on Tobacco Control: updated January 2020
  • Section 8.3 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders: updated January 2020
  • Section 5.7 The home environment: updated December 2019 
  • Section 7.16 Pharmacotherapies: updated December 2019 
  • Chapter 14 Social marketing and public education campaigns: updated November 2019
  • Section 10.18.1 Tobacco Free Portfolios: published November 2019
  • Section 11.11 Tobacco advertising and promotion: Internet promotion: updated November 2019
  • Section 13.2 Tobacco taxes in Australia: updated November 2019 
  • Section 9.1 Socio-economic position and disparities in tobacco exposure and use: updated November 2019 
  • Section 9.2.4 Changes in the prevalence of smoking among students in schools in areas of varying levels of disadvantage: updated November 2019
  • Section 11A.6 Plain packaging—International flow-on effects: updated November 2019
  • Sections 9.8 Are current strategies to discourage smoking in Australia inequitable? and 9.9 Are there inequalities in access to and use of treatment for dependence on tobacco-delivered nicotine?: updated October 2019
  • Section 5.11 Accessibility of tobacco products to young smokers: updated October 2019
  • Section 7.17 Contingency management/incentives: updated October 2019
  • Section 13.11 Are tobacco taxes regressive?; updated September 2019
  • Chapter 19 The WHO Framework Convention on Tobacco Control; updated September 2019 
  • Section 4.7 Estimates of morbidity and mortality attributable to secondhand smoke; updated September 2019
  • Section 5.5 Temperament, mental health problems and self-concept; updated September 2019
  • Section 11A.9 Real-world research on the effects of plain packaging; updated September 2019
  • Section 1.10.1 Prevalence of smoking in other high-risk sub-groups of the population; Smoking in pregnancy: updated August 2019
  • Section 8.3 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders: updated August 2019
  • Section 7.11 Smoking cessation and pregnancy: updated August 2019
  • Section 4.5 Prevalence of exposure to SHS in the home: updated July 2019
  • Chapter 5 Influences on the uptake and prevention of smoking Section 5.4 Adolescence and brain maturation; Section 5.6 Intentions, attitudes and beliefs; Section 5.9 The educational environment: updated August 2019
  • Section 11A.6 Plain packaging: International flow-on effects: updated July 2019
  • Section 15.6 Smoking bans in the home and car; Section 15.7 Legislation to ban smoking in public spaces: updated July 2019
  • InDepth 12A Health warnings: updated July 2019
  • Section 10.3 The manufacturing and wholesaling industry in Australia - major international companies: updated August 2019
  • Section 1.3 Prevalence of smoking—adults: updated August 2019
  • Section 13.3 The price of tobacco products in Australia: updated July 2019
  • Section 14.3 Tobacco-control campaigns in Australia: experience: updated July 2019
  • Section 8.13 Policies for advancing tobacco control programs among Aboriginal and Torres Strait Islander peoples: updated July 2019
  • Section 10.11 Corporate responsibility and the birth of good corporate citizenship: updated July 2019
  • Section 2.1 Production and trade data as a basis for estimating tobacco consumption: updated July 2019
  • Section 3.1 Smoking and heart disease: updated July 2019
  • Section 2.3 Self-reported measures of tobacco consumption: updated June 2019
  • Section 13.2 Tobacco taxes in Australia: updated June 2019
  • Section 3.0 Health effects: Introduction: updated June 2019
  • Section 3.30 Total burden of death and disease attributable to tobacco by disease category: updated June 2019
  • Section 3.34 Public perceptions of tobacco as a drug, and knowledge and beliefs about the health consequences of smoking: updated May 2019
  • Section 18B.10 Key Australian and international position statements on e-cigarettes, health, and options for regulation: updated May 2019 
  • InDepth 18C Heated tobacco (‘heat-not-burn’) products: updated March 2019
  • Section 2.2 Dutiable tobacco products as an estimate of tobacco consumption: updated May 2019
  • Section 10.0 The tobacco industry in Australian society: Introduction; 10.2 The global tobacco manufacturing industry; 10.3 The manufacturing and wholesaling industry in Australia—major international companies; 10.4 Other importers operating in the Australian market; 10.5 Retailing of tobacco products in Australia; 10.6 Retail value and volume of the Australian tobacco market; 10.7 Market share and brand share in Australia: updated May 2019
  • Section 5.0 Influences on the uptake and prevention of smoking: Introduction: updated April 2019
  • Section 1.6 Prevalence of smoking—teenagers: updated February 2019 
  • Section 18B.8 Electronic cigarettes (e-cigarettes): Legal status in Australia: updated March 2019
  • Section 5.1 Stages in the uptake of smoking; Section 5.2 Factors influencing uptake by young people: overview; and Section 5.3 Early biological factors: updated February 2019 
  • Section 10.7 Market share and brand share in Australia: updated February 2019, including a  comprehensive list of factory-made cigarettes and roll-your-own tobacco products available for sale at major Australian retailers
  • Section 10A.7 Mechanisms of influence—political lobbying: updated February 2019
  • Section 11.11 Internet promotion: updated February 2019
  • Section 18B.11 Electronic cigarettes (e-cigarettes): Public perceptions of e-cigarettes: updated February 2019
  • Section 18B.9 Electronic cigarettes (e-cigarettes): International regulatory review and Section 18B.10 Key Australian and international position statements on e-cigarettes, health, and options for regulation: updated February 2019
  • Section 1.3 Prevalence of smoking—adults: updated February 2019
  • Section 18B.7 Electronic cigarettes (e-cigarettes): Potential positive impacts: updated January 2019
  • Section 18B.1 Electronic cigarettes (e-cigarettes):The e-cigarette market and Section 18B.2 Advertising and promotion: updated January 2019
  • Section 13.2 Tobacco taxes in Australia: updated November 2018
  • Section 18B.5 Electronic cigarettes (e-cigarettes): Health risks of e-cigarettes and Section 18B.6 Potential negative impacts: updated November 2018
  • **New InDepth** 11A Packaging as promotion: Evidence for and effects of plain packaging: published November 2018
  • Section 9.9 Are there inequalities in access to and use of treatment for dependence on tobacco-delivered nicotine?: updated November 2018
  • Section 8.3 Prevalence of tobacco use among Aboriginal peoples and Torres Strait Islanders: updated October 2018
  • Section 7.16 Pharmacotherapies: updated October 2018
  • Section 18B.3 Electronic cigarettes (e-cigarettes): Extent of use and Section 18B.4 Safety and abuse potential: updated October 2018
  • Section 10.17 Public attitudes to the tobacco industry: updated October 2018
  • Section 11.4 State and territory legislation: updated September 2018
  • Section 11.9 Retail promotion and access: updated September 2018
  • Section 5.21 Reducing tobacco and supply: updated September 2018
  • Section 18.4 Low nicotine - nicotine reduction: updated September 2018
  • Chapter 19 The WHO Framework Convention on Tobacco Control: updated September 2018
  • Section 8.3.5  Prevalence of smoking among pregnant Aboriginal and Torres Strait Islander women: updated September 2018
  • Section 7.11.2 Rates of smoking during pregnancy: updated September 2018
  • Section 1.10.1 Smoking in pregnancy: updated September 2018
  • Section 15.9 Effectiveness of smokefree legislation in reducing exposure to tobacco toxins, improving health, and changing smoking behaviours: updated June 2018
  • Section 8.3 Prevalence of tobacco use among Aboriginal and Torres Strait Islander peoples: updated June 2018
  • Section 1.3 Prevalence of smoking—adults: updated June 2018
  • **New sections** 16.4 Criminal cases against the tobacco industry and 16.5 Legal cases initiated by tobacco industry: published May 2018
  • **New InDepth** InDepth 10A Tobacco industry: Strategies for influence; and Section 10.18 The investment of public funds in tobacco—the case for divestment: published May 2018
  • Sections 10.17 Public attitudes to the tobacco industry; and 10.19 The future of the tobacco industry: updated May 2018 
  • Section 8.7 Morbidity and mortality caused by smoking among Aboriginal and Torres Strait Islander peoples: updated May 2018
  • Section 5.21 Reducing tobacco access and supply: updated May 2018
  • Section 13.2 Tobacco taxes in Australia: updated March 2018
  • Section 7.12 Smoking and mental health: updated March 2018
  • Section 11.10.9 Plain packaging: International flow-on effects: updated April 2018
  • **New chapter** InDepth 18C Heated tobacco (‘heat-not-burn’) products: published March 2018
  • Section 10.20 Tobacco industry intervention in political and judicial processes—political donations: updated March 2018
  • Chapter 6 Addiction: updated March 2018
  • Section 9.1 Socio-economic position and disparities in tobacco exposure and use and Section 9.2 Socio-economic disparities in tobacco exposure and use: are the gaps widening?: updated January 2018
  • Section 7.6 How smokers go about quitting: updated January 2018
  • Section 2.3 Self-reported measures of tobacco consumption: updated December 2017
  • Chapter 1 Prevalence (including an analysis of NDSHS data for detailed prevalence figures and trends only available in Facts & Issues): updated December 2017
  • Sections 10.1 The tobacco growing industry; 10.2 The global tobacco manufacturing industry; 10.3 The manufacturing and wholesaling industry in Australia—major international companies; 10.4 Other importers operating in the Australian market; 10.6 Retail value and volume of the Australian tobacco market; and 10.7 Market share and brand share in Australia: updated November 2017
  • New section: 10.5 Retailing of tobacco products in Australia: published November 2017
  • Section 3.30 Total burden of death and disease attributable to tobacco by disease category: updated November 2017
  • Section 10.15 Ethical issues related to farming: updated August 2017
  • Section 18B.2 Electronic cigarettes (e-cigarettes): Advertising and promotion and Section 18B.11 Public perceptions of e-cigarettes: updated November 2017
  • Section 18B.1 Electronic cigarettes (e-cigarettes): The e-cigarette market: updated October 2017
  • Appendix 1.4 Australian and state/territory tobacco control strategies: updated October 2017
  • Section 13.3 The price of tobacco products in Australia: updated September 2017
  • Section 10.8 Trends in products and packaging and Section 10.9 Brand portfolio strategies in the Australia market: updated September 2017
  • Section 18B.4 Electronic cigarettes (e-cigarettes): Safety and abuse potential and Section 18B.9 International regulatory overview: updated September 2017
  • Section 18B.3 Electronic cigarettes (e-cigarettes): Extent of use and Section 18B.8 Legal status: updated August 2017
  • Table 15.7.10 Smokefree legislation in Australian states and territories: updated July 2017
  • Section 10.10 Tobacco industry document repositories: updated July 2017
  • Section 10.12 Revised stance on health issues: updated July 2017
  • Section 1.11 Prevalence of use of different types of tobacco products: updated June 2017
  • Sections 1.4  and 1.5 Prevalence of smoking, current prevalence in adults, young adults and older adults: updated June 2017
  • Section 15.4 Smoking bans in key public areas and environments: updated January 2017
  • Section 15.6 Smoking bans in domestic environments: updated January 2017
  • Chapter 4 The health effects of secondhand smoke: last updated January 2017
  • Section 13.6 Revenue from tobacco taxes in Australia: updated December 2016
  • Chapter 9 Smoking and social disadvantage: last updated December 2016
  • Section 10.14 The environmental impact of tobacco production and Section 10.16 The environmental impact of tobacco use: last updated December 2016
  • A comprehensive timeline of the history of tobacco in Australia: published December 2016
  • New section: 11.10.13 Effects of plain packaging in Australia post-implementation: published November 2016
  • Chapter 7 Smoking cessation: last updated October 2016
  • Section 15.7 Commonwealth and state/territory legislation to ban smoking in public spaces: last updated October 2016
  • Commonwealth and state/territory legislation on tobacco advertising & promotion: last updated October 2016
  • Chapter 8 Tobacco use among Aboriginal peoples and Torres Strait Islanders: last updated September 2016
  • **New chapter** Chapter 18: Potential for harm reduction in tobacco control (includes e-cigarettes): published August 2016
  • Section 11.9 Retail promotion and access: last updated and significantly expanded April 2016
  • Chapter 1 Prevalence (including an analysis of NDSHS data for detailed prevalence figures and trends only available in Facts & Issues): last updated December 2015
  • Chapter 3  Health effects of active smoking: last updated May 2015 
  • Links at the end of each section, where recent news and research relevant to each topic is compiled
  • Chapter 5 Influences on the uptake and prevention of smoking: last updated November 2014